278 related articles for article (PubMed ID: 12066214)
1. Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination.
Osugi H; Takada N; Takemura M; Kaseno S; Lee S; Ueno M; Tanaka Y; Fukuhara K; Fujiwara Y; Kinoshita H
Oncol Rep; 2002; 9(4):811-5. PubMed ID: 12066214
[TBL] [Abstract][Full Text] [Related]
2. [The clinical effect of TS-1 in advanced and recurrent gastric cancer with peritoneal dissemination].
Inaba Y; Watabe S; Ohe S; Kamio Y; Koyama M; Hayashi K; Chiba M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):239-44. PubMed ID: 11865630
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.
Fujitani K; Tsujinaka T; Hirao M
Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112
[TBL] [Abstract][Full Text] [Related]
4. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of novel oral fluoropyrimidine anticancer drug, TS-1 for advanced and recurrent gastric cancer patients].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1297-301. PubMed ID: 14518409
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
Tanabe K; Yoshida K; Hamai Y; Ukon K; Ohta K; Hihara J; Toge T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1145-8. PubMed ID: 16121917
[TBL] [Abstract][Full Text] [Related]
7. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
[TBL] [Abstract][Full Text] [Related]
8. [TS-1 was prescribed for a patient with stomach cancer with peritoneal dissemination who survived for 3 years and 2 months].
Mikata S; Iwase K; Higaki J; Miyazaki M; Yoshikawa S; Ide H; Kim H; Oimatsu N; Inayama M; Kamiike W
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1225-7. PubMed ID: 15332548
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of S-1 in patients with disseminated gastric cancer.
Kitamura Y; Hayashi K; Sasagawa T; Oguma H; Takasaki K
Drugs Exp Clin Res; 2003; 29(3):125-30. PubMed ID: 14708458
[TBL] [Abstract][Full Text] [Related]
10. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
Ebisui C; Souma I; Hayashi N; Fukuchi N; Izawa H; Yoshida T; Sakita I; Hasuike Y; Fujimoto T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1861-3. PubMed ID: 15553740
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of gastric cancer with peritoneal dissemination that responded to TS-1 without progression or recurrence for over 3 years].
Tamura S; Miki H; Kittaka N; Nakata K; Kim C; Takiuchi D; Okada K; Okamura S; Aihara T; Sugimoto K; Ohzato H; Tomita N; Takatsuka Y
Gan To Kagaku Ryoho; 2006 Feb; 33(2):243-6. PubMed ID: 16484865
[TBL] [Abstract][Full Text] [Related]
12. [Results of treatment of far advanced and recurrent stomach cancer with TS-1].
Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N
Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology.
Ako E; Ohira M; Yamashita Y; Kubo N; Muguruma K; Yashiro M; Sawada T; Nakata B; Kato Y; Hirakawa K
Hepatogastroenterology; 2008; 55(86-87):1939-42. PubMed ID: 19102427
[TBL] [Abstract][Full Text] [Related]
14. [A case of advanced gastric cancer successfully treated with TS-1].
Yokota M; Ouchi J; Miyagi Y; Matsuo S; Uchimura K; Sumii T; Iguchi H; Funakoshi A
Gan To Kagaku Ryoho; 2002 Feb; 29(2):293-5. PubMed ID: 11865636
[TBL] [Abstract][Full Text] [Related]
15. [A case of peritoneal metastasis of gastric cancer responding to TS-1, administered for four consecutive weeks with two-week rests].
Naka Y; Yoshikawa K; Nezu R; Fujikawa M; Fujii M; Emoto T; Yoshioka Y; Komaki T; Yokota T; Adachi I; Kamei A
Gan To Kagaku Ryoho; 2003 Jun; 30(6):855-8. PubMed ID: 12852356
[TBL] [Abstract][Full Text] [Related]
16. [A case of advanced colon cancer with peritoneal dissemination completely responding to TS-1].
Taguchi S; Osugi H; Takemura M; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
Gan To Kagaku Ryoho; 2004 Feb; 31(2):259-61. PubMed ID: 14997764
[TBL] [Abstract][Full Text] [Related]
17. [A case of heterochronous liver metastasis of gastric cancer favorably responding to TS-1].
Tokuhara T; Hara A; Takahashi Y; Harada T; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Jun; 31(6):917-9. PubMed ID: 15222112
[TBL] [Abstract][Full Text] [Related]
18. [Complete response in an elderly patient with advanced gastric cancer treated with TS-1].
Ijuin H; Tokitou D; Adachi E; Imamura K; Imamura S; Arima T; Atsuchi Y; Nakano K; Kotobuki S
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2165-8. PubMed ID: 15628764
[TBL] [Abstract][Full Text] [Related]
19. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of advanced gastric cancer with peritoneal dissemination acquired long-term response three years or more by postoperative treatment with oral anticancer drug TS-1].
Shikano T; Koshikawa K; Kiriyama K; Wada M; Taniguchi K; Suenaga H
Gan To Kagaku Ryoho; 2006 Jan; 33(1):87-90. PubMed ID: 16410704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
